{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T20:27:16Z","timestamp":1788553636538,"version":"build-2803163510"},"reference-count":54,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T00:00:00Z","timestamp":1756944000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82172356"],"award-info":[{"award-number":["82172356"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016804","name":"Natural Science Foundation of Shenzhen Municipality","doi-asserted-by":"publisher","award":["JCYJ20230807115124048"],"award-info":[{"award-number":["JCYJ20230807115124048"]}],"id":[{"id":"10.13039\/100016804","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016804","name":"Natural Science Foundation of Shenzhen Municipality","doi-asserted-by":"publisher","award":["JCYJ20230807115112024"],"award-info":[{"award-number":["JCYJ20230807115112024"]}],"id":[{"id":"10.13039\/100016804","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p>Worldwide cancer statistics have shown that breast cancer dominates female cancer incidence and remains a leading cause of death. The Systemic Immune-Inflammation Index (SII) is a new prognostic indicator of systemic inflammation used to assess systemic immune-inflammatory response levels in the human body. It is associated with the prognosis of various diseases, such as malignant tumors, cardiovascular diseases, and autoimmune diseases. Although SII offers valuable information for diagnosing and predicting the risk of female breast cancer (FBC), the association between SII and FBC has not yet been analyzed. Therefore, the relationship between SII and FBC was investigated in this study. Multivariate logistic regression, model fit assessment using Akaike Information Criterion (AIC) and Bayesian Information Criterion (BIC), and smoothing curve fitting were applied to examine the correlation between SII and FBC using data from the National Health and Nutrition Examination Survey (NHANES) 2001-2018. Then the stability of their association was further examined using subgroup analysis and interaction tests among populations. Results showed a positive correlation between SII and FBC in 17,044 participants with age\u2009\u2265\u200920 years. In the fully adjusted model, every 100-unit increase in SII was accompanied by a 3% increased odds of FBC prevalence [OR = 1.03 (95% CI: 1.01, 1.05)]. Individuals in the highest quartile of SII exhibited 44% increased odds of FBC prevalence than those in the lowest quartile [OR = 1.44 (95% CI: 1.11, 1.88)]. Model fitness assessment using AIC and BIC criteria demonstrated that multivariable-adjusted models exhibited better fit compared to unadjusted models for both continuous and categorical SII specifications. Receiver Operating Characteristic (ROC) curve analysis demonstrated that SII exhibited excellent diagnostic capability for breast cancer, with the area under the ROC curve (AUC) of 0.816 (95% CI: 0.801\u20130.831), comparable to NLR (AUC\u2009=\u20090.816) and neutrophil counts (AUC\u2009=\u20090.815). In disease-specific performance comparison, SII\u2019s predictive ability for breast cancer (AUC\u2009=\u20090.816) was slightly superior to that for hypertension (AUC\u2009=\u20090.799), with the difference being statistically significant (<jats:italic>P\u2009<\/jats:italic>=\u20090.0407). Our findings confirmed that SII was a promising biomarker associated with FBC prevalence, and it may provide valuable insights into early screening and personalized treatment strategies.<\/jats:p>","DOI":"10.1371\/journal.pone.0330571","type":"journal-article","created":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T17:25:22Z","timestamp":1757006722000},"page":"e0330571","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":5,"title":["Association between Systemic Immune-Inflammation Index and female breast cancer based on NHANES data (2001\u20132018): A cross-sectional study"],"prefix":"10.1371","volume":"20","author":[{"given":"Juan","family":"Xiong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deju","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuntao","family":"Quan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7167-9343","authenticated-orcid":true,"given":"Ni","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,9,4]]},"reference":[{"issue":"3","key":"pone.0330571.ref001","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"H Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"pone.0330571.ref002","doi-asserted-by":"crossref","first-page":"1486264","DOI":"10.3389\/fphar.2024.1486264","article-title":"Anti-breast cancer effects of dairy protein active peptides, dairy products, and dairy protein-based nanoparticles","volume":"15","author":"D Zhang","year":"2024","journal-title":"Front Pharmacol"},{"issue":"10","key":"pone.0330571.ref003","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.annonc.2021.06.023","article-title":"Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021","volume":"32","author":"HJ Burstein","year":"2021","journal-title":"Ann Oncol"},{"key":"pone.0330571.ref004","doi-asserted-by":"crossref","first-page":"1468977","DOI":"10.3389\/fphar.2024.1468977","article-title":"Plant protein-derived anti-breast cancer peptides: sources, therapeutic approaches, mechanisms, and nanoparticle design","volume":"15","author":"D Zhang","year":"2025","journal-title":"Front Pharmacol"},{"issue":"1","key":"pone.0330571.ref005","first-page":"17","article-title":"Cancer statistics, 2023","volume":"73","author":"RL Siegel","year":"2023","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"pone.0330571.ref006","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.21037\/tcr-20-2119","article-title":"Prognostic factors for patients with metastatic breast cancer: a literature review","volume":"10","author":"M Hu","year":"2021","journal-title":"Transl Cancer Res"},{"key":"pone.0330571.ref007","doi-asserted-by":"crossref","first-page":"102339","DOI":"10.1016\/j.ctrv.2022.102339","article-title":"Global challenges and policy solutions in breast cancer control","volume":"104","author":"D Trapani","year":"2022","journal-title":"Cancer Treat Rev"},{"issue":"3","key":"pone.0330571.ref008","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.jtho.2018.11.023","article-title":"Biomarkers in lung cancer screening: achievements, promises, and challenges","volume":"14","author":"LM Seijo","year":"2019","journal-title":"J Thorac Oncol"},{"issue":"8","key":"pone.0330571.ref009","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.pan.2024.10.012","article-title":"Early detection of pancreatic cancer: study design and analytical considerations in biomarker discovery and early phase validation studies","volume":"24","author":"LM Smith","year":"2024","journal-title":"Pancreatology"},{"key":"pone.0330571.ref010","doi-asserted-by":"crossref","first-page":"155567","DOI":"10.1016\/j.prp.2024.155567","article-title":"Emerging methods and techniques for cancer biomarker discovery","volume":"262","author":"TC Dakal","year":"2024","journal-title":"Pathol Res Pract"},{"issue":"1","key":"pone.0330571.ref011","first-page":"1","article-title":"A review of prognostic and predictive biomarkers in breast cancer","volume":"23","author":"E Tarighati","year":"2023","journal-title":"Clin Exp Med"},{"issue":"1","key":"pone.0330571.ref012","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/s12885-024-11931-5","article-title":"Healthy lifestyles, systemic inflammation and breast cancer risk: a mediation analysis","volume":"24","author":"Y Zhang","year":"2024","journal-title":"BMC Cancer"},{"issue":"1","key":"pone.0330571.ref013","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12916-021-02193-0","article-title":"Circulating inflammatory cytokines and risk of five cancers: a Mendelian randomization analysis","volume":"20","author":"E Bouras","year":"2022","journal-title":"BMC Med"},{"issue":"43","key":"pone.0330571.ref014","doi-asserted-by":"crossref","first-page":"75381","DOI":"10.18632\/oncotarget.18856","article-title":"Prognostic role of systemic immune-inflammation index in solid tumors: a systematic review and meta-analysis","volume":"8","author":"J-H Zhong","year":"2017","journal-title":"Oncotarget"},{"issue":"8","key":"pone.0330571.ref015","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s10654-021-00752-6","article-title":"Systemic inflammation markers and cancer incidence in the UK Biobank","volume":"36","author":"TH N\u00f8st","year":"2021","journal-title":"Eur J Epidemiol"},{"issue":"2","key":"pone.0330571.ref016","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1245\/s10434-024-16454-8","article-title":"Prognostic value of the baseline Systemic Immune-Inflammation Index in HER2-positive metastatic breast cancer: exploratory analysis of two prospective trials","volume":"32","author":"J Pang","year":"2025","journal-title":"Ann Surg Oncol"},{"key":"pone.0330571.ref017","doi-asserted-by":"crossref","first-page":"704235","DOI":"10.3389\/fsurg.2021.704235","article-title":"Postoperative Systemic Immune-Inflammation Index (SII): a superior prognostic factor of endometrial cancer","volume":"8","author":"Y Huang","year":"2021","journal-title":"Front Surg"},{"issue":"34","key":"pone.0330571.ref018","doi-asserted-by":"crossref","first-page":"6261","DOI":"10.3748\/wjg.v23.i34.6261","article-title":"Systemic immune-inflammation index for predicting prognosis of colorectal cancer","volume":"23","author":"J-H Chen","year":"2017","journal-title":"World J Gastroenterol"},{"key":"pone.0330571.ref019","doi-asserted-by":"crossref","first-page":"865643","DOI":"10.3389\/fimmu.2022.865643","article-title":"The prognostic and clinicopathological significance of systemic immune-inflammation index in bladder cancer","volume":"13","author":"J Li","year":"2022","journal-title":"Front Immunol"},{"issue":"8","key":"pone.0330571.ref020","article-title":"Systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio can predict clinical outcomes in patients with metastatic non-small-cell lung cancer treated with nivolumab","volume":"33","author":"J Liu","year":"2019","journal-title":"J Clin Lab Anal"},{"key":"pone.0330571.ref021","doi-asserted-by":"crossref","first-page":"939","DOI":"10.2147\/OTT.S434193","article-title":"Predictive significance of systemic immune-inflammation index in patients with breast cancer: a retrospective cohort study","volume":"16","author":"Y Zhou","year":"2023","journal-title":"Onco Targets Ther"},{"issue":"1","key":"pone.0330571.ref022","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.1038\/s41598-021-82659-6","article-title":"The association between plant-based dietary patterns and risk of breast cancer: a case-control study","volume":"11","author":"S Rigi","year":"2021","journal-title":"Sci Rep"},{"issue":"9","key":"pone.0330571.ref023","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.3390\/nu12092652","article-title":"Logistic LASSO regression for dietary intakes and breast cancer","volume":"12","author":"AJ McEligot","year":"2020","journal-title":"Nutrients"},{"key":"pone.0330571.ref024","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/s12935-020-01308-6","article-title":"Prognostic value of the systemic immune-inflammation index in patients with breast cancer: a meta-analysis","volume":"20","author":"Y Zhang","year":"2020","journal-title":"Cancer Cell Int"},{"issue":"5","key":"pone.0330571.ref025","doi-asserted-by":"crossref","first-page":"609","DOI":"10.21037\/gs-23-55","article-title":"Association between the systemic immune-inflammation index and the efficacy of neoadjuvant chemotherapy, prognosis in HER2 positive breast cancer-a retrospective cohort study","volume":"12","author":"Q Gu","year":"2023","journal-title":"Gland Surg"},{"key":"pone.0330571.ref026","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.2147\/IJGM.S411592","article-title":"High levels of SII and PIV are the risk factors of axillary lymph node metastases in breast cancer: a retrospective study","volume":"16","author":"L Tong","year":"2023","journal-title":"Int J Gen Med"},{"key":"pone.0330571.ref027","doi-asserted-by":"crossref","first-page":"4471","DOI":"10.2147\/CMAR.S197623","article-title":"Prognostic significance of systemic immune-inflammation index in triple-negative breast cancer","volume":"11","author":"J Liu","year":"2019","journal-title":"Cancer Manag Res"},{"issue":"1","key":"pone.0330571.ref028","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1186\/s12885-022-09312-x","article-title":"Prognostic significance of the skeletal muscle index and systemic inflammatory index in patients with lymph node-positive breast cancer after radical mastectomy","volume":"22","author":"R Tang","year":"2022","journal-title":"BMC Cancer"},{"issue":"1","key":"pone.0330571.ref029","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/s12957-020-01974-w","article-title":"Prognostic prediction of systemic immune-inflammation index for patients with gynecological and breast cancers: a meta-analysis","volume":"18","author":"Y Ji","year":"2020","journal-title":"World J Surg Oncol"},{"issue":"4","key":"pone.0330571.ref030","doi-asserted-by":"crossref","first-page":"4002","DOI":"10.3390\/ijms24044002","article-title":"Crosstalk of inflammatory cytokines within the breast tumor microenvironment","volume":"24","author":"O Habanjar","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"3","key":"pone.0330571.ref031","doi-asserted-by":"crossref","first-page":"421","DOI":"10.17219\/acem\/62120","article-title":"IL-6, IL-8 and TNF-\u03b1 levels correlate with disease stage in breast cancer patients","volume":"26","author":"Y Ma","year":"2017","journal-title":"Adv Clin Exp Med"},{"key":"pone.0330571.ref032","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.breast.2018.03.013","article-title":"Social relationships, inflammation markers, and breast cancer incidence in the Women\u2019s Health Initiative","volume":"39","author":"EL Busch","year":"2018","journal-title":"Breast"},{"issue":"7","key":"pone.0330571.ref033","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1080\/10408363.2022.2050886","article-title":"Systematic review and meta-analysis of C-reactive protein as a biomarker in breast cancer","volume":"59","author":"MK Mikkelsen","year":"2022","journal-title":"Crit Rev Clin Lab Sci"},{"key":"pone.0330571.ref034","doi-asserted-by":"crossref","first-page":"4137","DOI":"10.2147\/OTT.S320111","article-title":"Preoperative Serum Hypersensitive-c-Reactive-Protein (Hs-CRP) to albumin ratio predicts survival in patients with luminal b subtype breast cancer","volume":"14","author":"X Liu","year":"2021","journal-title":"Onco Targets Ther"},{"issue":"3","key":"pone.0330571.ref035","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2020.06.007","article-title":"IL6\/STAT3 signaling hijacks estrogen receptor \u03b1 enhancers to drive breast cancer metastasis","volume":"38","author":"R Siersb\u00e6k","year":"2020","journal-title":"Cancer Cell"},{"issue":"12","key":"pone.0330571.ref036","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.3390\/molecules13122975","article-title":"Berberine suppresses TNF-alpha-induced MMP-9 and cell invasion through inhibition of AP-1 activity in MDA-MB-231 human breast cancer cells","volume":"13","author":"S Kim","year":"2008","journal-title":"Molecules"},{"key":"pone.0330571.ref037","doi-asserted-by":"crossref","DOI":"10.21037\/tcr.2019.03.24","article-title":"Pathological and molecular characteristics of inflammatory breast cancer","volume":"8","author":"M Di Bonito","year":"2019","journal-title":"Transl Cancer Res"},{"issue":"1","key":"pone.0330571.ref038","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000018571","article-title":"Prognostic impact of elevated pre-treatment systemic immune-inflammation index (SII) in hepatocellular carcinoma: a meta-analysis","volume":"99","author":"B Wang","year":"2020","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"pone.0330571.ref039","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/s12876-025-03749-7","article-title":"Clinical value of systemic immunoinflammatory index in predicting recurrence and metastasis in patients with primary liver cancer","volume":"25","author":"Y Deng","year":"2025","journal-title":"BMC Gastroenterol"},{"key":"pone.0330571.ref040","doi-asserted-by":"crossref","first-page":"537140","DOI":"10.3389\/fonc.2021.537140","article-title":"Prognostic value of pretreatment systemic immune-inflammation index in gastric cancer: a meta-analysis","volume":"11","author":"Y Qiu","year":"2021","journal-title":"Front Oncol"},{"key":"pone.0330571.ref041","doi-asserted-by":"crossref","first-page":"10273","DOI":"10.2147\/JIR.S499094","article-title":"The Effect of Systemic Immune-Inflammatory Index (SII) and Prognostic Nutritional Index (PNI) in early gastric cancer","volume":"17","author":"Y Jing","year":"2024","journal-title":"J Inflamm Res"},{"key":"pone.0330571.ref042","doi-asserted-by":"crossref","first-page":"814727","DOI":"10.3389\/fonc.2022.814727","article-title":"Prognostic significance of the Systemic Immune-Inflammation Index (SII) in patients with small cell lung cancer: a meta-analysis","volume":"12","author":"Y Zhou","year":"2022","journal-title":"Front Oncol"},{"issue":"1","key":"pone.0330571.ref043","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.1038\/s41598-019-39150-0","article-title":"Prognostic value of preoperative systemic immune-inflammation index in patients with cervical cancer","volume":"9","author":"H Huang","year":"2019","journal-title":"Sci Rep"},{"issue":"1","key":"pone.0330571.ref044","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12967-023-03924-y","article-title":"Prognostic value of the pretreatment systemic immune-inflammation index in patients with prostate cancer: a systematic review and meta-analysis","volume":"21","author":"L Meng","year":"2023","journal-title":"J Transl Med"},{"issue":"5","key":"pone.0330571.ref045","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1007\/s11596-018-1946-6","article-title":"Predictive values of postoperative and dynamic changes of inflammation indexes in survival of patients with resected colorectal cancer","volume":"38","author":"Z-Q Zhou","year":"2018","journal-title":"Curr Med Sci"},{"issue":"11","key":"pone.0330571.ref046","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1038\/s41416-019-0458-x","article-title":"Predictive value of inflammatory markers for cancer diagnosis in primary care: a prospective cohort study using electronic health records","volume":"120","author":"J Watson","year":"2019","journal-title":"Br J Cancer"},{"key":"pone.0330571.ref047","doi-asserted-by":"crossref","first-page":"710538","DOI":"10.3389\/fonc.2021.710538","article-title":"Long non-coding RNAs as potential diagnostic and prognostic biomarkers in breast cancer: progress and prospects","volume":"11","author":"C Lu","year":"2021","journal-title":"Front Oncol"},{"issue":"10","key":"pone.0330571.ref048","doi-asserted-by":"crossref","first-page":"7659","DOI":"10.1007\/s13277-015-3469-0","article-title":"Clinical significance of high expression of circulating serum lncRNA RP11-445H22.4 in breast cancer patients: a Chinese population-based study","volume":"36","author":"N Xu","year":"2015","journal-title":"Tumour Biol"},{"key":"pone.0330571.ref049","doi-asserted-by":"crossref","first-page":"1355738","DOI":"10.3389\/fendo.2024.1355738","article-title":"Association between systemic immunity-inflammation index and sex hormones in children and adolescents aged 6-19","volume":"15","author":"Z Gao","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"pone.0330571.ref050","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s13058-022-01553-9","article-title":"Sex steroid hormones and risk of breast cancer: a two-sample Mendelian randomization study","volume":"24","author":"A Nounu","year":"2022","journal-title":"Breast Cancer Res"},{"issue":"7770","key":"pone.0330571.ref051","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/s41586-019-1450-6","article-title":"Loss of p53 triggers WNT-dependent systemic inflammation to drive breast cancer metastasis","volume":"572","author":"MD Wellenstein","year":"2019","journal-title":"Nature"},{"issue":"3","key":"pone.0330571.ref052","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1148\/radiol.2017171218","article-title":"Supplemental screening breast US in women with negative mammographic findings: effect of routine axillary scanning","volume":"286","author":"SH Lee","year":"2018","journal-title":"Radiology"},{"issue":"2","key":"pone.0330571.ref053","article-title":"The Systemic Immune-Inflammation Index is a predictor of chemotherapy sensitivity and disease-free survival in patients with hormone receptor-positive human epidermal growth factor receptor 2-negative breast cancer","volume":"25","author":"X Liu","year":"2025","journal-title":"Clin Breast Cancer"},{"key":"pone.0330571.ref054","doi-asserted-by":"crossref","first-page":"1165510","DOI":"10.3389\/fimmu.2023.1165510","article-title":"Development and validation of a new prognostic immune-inflammatory-nutritional score for predicting outcomes after curative resection for intrahepatic cholangiocarcinoma: A multicenter study","volume":"14","author":"J Zhu","year":"2023","journal-title":"Front Immunol"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0330571","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T17:25:33Z","timestamp":1757006733000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0330571"}},"subtitle":[],"editor":[{"given":"Marcus Tolentino","family":"Silva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,9,4]]},"references-count":54,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,9,4]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0330571","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,4]]}}}